Overview
- 125 inspections across 109 sites are on record.
- 332 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-13.
At a glance
Inspections
125
Sites
109
Observations
332
Career since
Mar 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | 13 Apr 2026 | Human Drugs | |
| Alora Pharmaceuticals | 13 Apr 2026 | Human Drugs | On file |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 27 Mar 2026 | Human Drugs | On file |
| PETNET Solutions, Inc. | 2 Mar 2026 | Human Drugs | On file |
| PTI Georgia, LLC | 16 Jan 2026 | Human Drugs | On file |
Sites inspected
Acella Pharmaceuticals, LLCAlpharetta, United States1 insp.
Alora PharmaceuticalsAlpharetta, United States1 insp.
FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle Park, United States1 insp.
PETNET Solutions, Inc.Atlanta, United States1 insp.
PTI Georgia, LLCRoyston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Samantha E Cleek8 shared
Rita K Kabaso6 shared
Song Y Lavalais4 shared
Inga M Warr3 shared
Kemejumaka N Opara3 shared
Gideon N Esuzor3 shared
Steven A Brettler2 shared
Pratik S Upadhyay2 shared
Tomika L Crafter2 shared
Andrew O Ejiofor2 shared
Full investigator report
Get the verbatim findings behind Veronica Fuentes' 332 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site